HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization and use of an allotype-specific monoclonal antibody to placental alkaline phosphatase in the study of cancer-related phosphatase polymorphism.

Abstract
The hybridoma technique was used to produce an allotype-specific monoclonal antibody (F11) that reacts with the products of the S, I, and D alleles of PLAP but not of the F allele. Serum and ascites samples from patients with different cancers containing high levels of PLAP were tested for reactivity with F11. These tumor-derived PLAPs were of the Nagao type as shown by their sensitivity to inhibition by L-leucine. This type of inhibition is exhibited also by the rare D allelic variant of PLAP but not by the common forms. Thus, it has been proposed that the Nagao enzyme represents reexpression of the D allele of PLAP. F11 reactive and nonreactive samples as well as samples with intermediate reactivity were found among the cancer sera and ascites. Our results show tha tumor-derived Nagao enzyme does not represent the reexpression of the D allele but instead, in spite of its distinct inhibition pattern, expresses the same genetic polymorphism that is found in the placenta.
AuthorsJ L Millán, T Stigbrand, E Ruoslahti, W H Fishman
JournalCancer research (Cancer Res) Vol. 42 Issue 6 Pg. 2444-9 (Jun 1982) ISSN: 0008-5472 [Print] United States
PMID7074621 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies, Monoclonal
  • Phenylalanine
  • Alkaline Phosphatase
  • Leucine
Topics
  • Alkaline Phosphatase (genetics, metabolism)
  • Alleles
  • Animals
  • Antibodies, Monoclonal
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Hybridomas (immunology)
  • Kinetics
  • Leucine (pharmacology)
  • Mice
  • Mice, Inbred BALB C
  • Neoplasms (enzymology)
  • Phenotype
  • Phenylalanine (pharmacology)
  • Placenta (enzymology)
  • Polymorphism, Genetic
  • Pregnancy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: